A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002)

Inclusion Criteria

• •To participate in the study, participants must meet the following requirements:
• •1. Must be a healthy male or female between 19 and 65 years of age with body mass index (BMI) between 18 and 35 kg/m2.
• •2. Must be a non-smoker.
• •3. Must agree to use an acceptable double-barrier method of birth control.
• •4. Must provide written informed consent after the study has been fully explained.
• •1. Pregnant or breastfeeding.
• •2. History of clinically significant diseases, as determined by the investigator.
• •3. Safety laboratory abnormalities at screening which are clinically significant.
• •4. Positive screening test for hepatitis B virus, hepatitis C virus or human immunodeficiency virus (HIV).
• •5. Use of chronic prescription medications within 3 months, acute prescription medications within 14 days, or systemic over-the-counter (OTC) medications within 7 days of the starting the study.
• •6. Current abuse of alcohol or illicit drugs, or history of alcohol or illicit drug abuse within the preceding two years.